The impact of arrhythmias in acute heart failure

Journal of Cardiac Failure

Volumn 10, Issue 4, 2004, Pages 279-284

  Benza, Raymond L ^a   Tallaj, José A ^a   Felker, G Michael ^b   Zabel, K Michael ^b   Kao, Walter ^b   Bourge, Robert C ^a   Pearce, Douglas ^b   Leimberger, Jeffrey D ^b   Borzak, Steven ^b   O'Connor, Christopher M ^b   Gheorghiade, Mihai ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b THT 328A ^*

Author keywords

Arrhythmias; Heart failure; Inotropic therapy

Indexed keywords

MILRINONE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FEMALE; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ARRHYTHMIA; ATRIAL FIBRILLATION; CARDIOTONIC AGENTS; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 4143085006     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.12.007     Document Type: Article

References (23)

1. Homes J., Kubo S.H., Cody R.J., Kligfield P. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol. 55:1985;146-151
2. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba Follow-Up Study. Am J Med. 98:1995;476-484
3. Doval H.C., Nul D.R., Grancelli H.O., Varini S.D., Soifer S., Corrado G., et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation. 94:1996;3198-3203
4. Kannel W.B., Plehn J.F., Cupples L.A. Cardiac failure and sudden death in the Framingham Study. Am Heart J. 115:1988;869-875
5. Middlekauff H.R., Stevenson W.G., Stevenson L.W. Prognostic significance of atrial fibrillation in advanced heart failure, A study of 390 patients. Circulation. 84:1991;40-48
6. Crijns H.J., Tjeerdsma G., de Kam P.J., Boomsma F., van Gelder I.C., van den Berg M.P., et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J. 21:2000;1238-1245
7. Mahoney P., Kimmel S., DeNofrio D., Wahl P., Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol. 83:1999;1544-1547
8. Cuffe M.S., Califf R.M., Adams K.F. Jr., Benza R., Bourge R., Colucci W.S., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 287:2002;1541-1547
9. Cuffe M.S., Califf R.M., Adams K.F., Bourge R.C., Colucci W., Massie B., et al. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. Am Heart J. 139:2000;15-22
10. Wilson J.R., Schwartz J.S., Sutton M.S., Ferraro N., Horowitz L.N., Reichek N., et al. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 2:1983;403-410
11. Drazner M.H., Rame J.E., Stevenson L.W., Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 345:2001;574-581
12. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldmanmd A.M., Francis G.S., et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration with the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of American. Circulation. 104:2001;2996-3007
13. Packer M., Carver J.R., Rodeheffer R.J., Ivanhoe R.J., DiBianco R., Zeldis S.M., et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 325:1991;1468-1475
14. Krell M.J., Kline E.M., Bates E.R., Hodgson J.M., Dilworth L.R., Laufer N., et al. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J. 112:1986;787-791
15. Anderson J.L., Baim D.S., Fein S.A., Goldstein R.A., LeJemtel T.H., Likoff M.J. Efficacy and safety of sustained (48 hours) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. J Am Coll Cardiol. 9:1987;711-722
16. Pflugfelder P.W., O'Neill B.J., Ogilvie R.I., Beanlands D.S., Tanser P.H., Tihal H., et al. A Canadian multicentre study of 48 h infusion of milrinone in patients with severe heart failure. Can J Cardiol. 7:1991;5-10
17. Biddle T.L., Benotti J.R., Creager M.A., Faxon D.P., Firth B.G., Fitzpatrick P.G., et al. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy. Am J Cardiol. 59:1987;1345-1350
18. Anderson J.L., Askins J.C., Gilbert E.M., Menlove R.L., Lutz J.R. Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. Am Heart J. 111:1986;466-474
19. Goldstein R.A., Geraci S.A., Gray E.L., Rinkenberger R.L., Dougherty A.H., Naccarelli G.V. Electrophysiologic effects of milrinone in patients with congestive heart failure. Am J Cardiol. 57:1986;624-628
20. Pozzoli M., Cioffi G., Traversi E., Pinna G.D., Cobelli F., Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol. 32:1998;197-204
21. Pardaens K., Van Cleemput J., Vanhaecke J., Fagard R.H. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients. Heart. 78:1997;564-568
22. Unverferth D.V., Magorien R.D., Moeschberger M.L., Baker P.B., Fetters J.K., Leier C.V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 54:1984;147-152
23. Deedwania P.C., Singh B.N., Ellenbogen K., Fisher S., Fletcher R., Singh S.N. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation. 98:1998;2574-2579